Sunday, May 10, 2020

CBSE to start answer sheet evaluation at 3,000 centres


CBSE to start answer sheet evaluation at 3,000 centres

Results will be announced after pending exams are over

10/05/2020, SPECIAL CORRESPONDENT,NEW DELHI

Long haul: In this photo dated March 18, 2020, Class 10 students outside an exam centre in Delhi.Sushil Kumar VermaSushil Kumar Verma

Nearly 3,000 schools affiliated to the Central Board of Secondary Education (CBSE) have been notified as evaluation centres, and will soon begin work on evaluating Class 10 and 12 board examinations which have been disrupted by the lockdown, Human Resource Development Minister Ramesh Pokhriyal Nishank said on Saturday.

In a memo issued on Saturday, the Union Home Ministry said that while all schools remained closed under the lockdown guidelines to prevent the spread of COVID-19, “special permission has been granted for the operation of 3,000 CBSE-affiliated schools selected as evaluation centres, for the limited purpose of work associated with the evaluation of answer sheets.” It said there was no restriction on the transport of answer sheets to the homes of evaluators unless they were located within a containment zone.

CBSE regional offices can also begin work in green and orange zones and function with limited restrictions in red zones, the Ministry memo said.

In total, 1.5 crore answer sheets in 173 subjects will be evaluated, said Mr. Nishank. Results will only be announced after the completion of the pending examinations in 29 subjects, which are to be held from July 1 to 15, he added.

Bengal not cooperating, Shah tells Mamata


Bengal not cooperating, Shah tells Mamata

Home Minister writes to CM on migrants’ travel

10/05/2020, VIJAITA SINGH,NEW DELHI

A May 7 photo of migrant workers hailing from West Bengal on the road at Gannavaram, Andhra Pradesh.T. VIJAYA_KUMAR

Union Home Minister Amit Shah sent a letter to West Bengal Chief Minister Mamata Banerjee on Friday stating that the State government was not allowing special trains and it was an “injustice” to stranded migrant workers.

The letter said that the Central government had facilitated more than two lakh migrants reach home.

“Migrants from West Bengal are also eager to reach home. Central govt. is facilitating but we are not getting expected support from W.B. State Government, which is not allowing the trains to reach W.B. This is injustice with W.B. migrant labourers. This will create further hardship for them,” the letter said.

The Railways has been running Shramik Special trains on the request of State governments to help the migrant workers stuck in various parts of the country due to the ongoing nationwide lockdown to reach home.

Maharashtra tops 20,000-mark; toll rises to 779


Maharashtra tops 20,000-mark; toll rises to 779

State registers 48 deaths, the highest in a day

10/05/2020, SPECIAL CORRESPONDENT,MUMBAI

Taking stock: New municipal commissioner Iqbal Singh Chahal, second from right, inspecting areas in Dharavi. Ravi Nadar

Maharashtra recorded 1,165 more COVID-19 cases, pushing the tally to 20,228 on Saturday. The State also recorded 48 deaths, the highest in a day, taking the toll to 779. The case fatality rate stands at 3.8%.

Of the 48 deaths, 27 were in Mumbai, 10 in Pune, eight in Malegaon and one each in Akola, Nanded and Amravati. While 21 of them were men, 27 were women. Health officials said 28 patients had such underlying conditions as diabetes, hypertension and heart disease, which made their recovery difficult.

The number of cases has doubled in the State in 10 days, while the number of deaths has doubled in 13 days.

Two districts in green

Only two districts — Wardha and Gadchiroli — remain in the green zone. All the other 33 districts have reported cases. Mumbai remains the worst affected, with nearly 64% of the cases and 63% of the deaths reported from the city alone.

The Mumbai Metropolitan Region, consisting of Thane, Navi Mumbai and other areas, has the highest number of cases in the State. The Pune Municipal Corporation has recorded 1,975 cases and 141 deaths.

Malegaon has emerged as an area of concern, with 472 cases and 20 deaths.

On Saturday, 330 patients were discharged from hospitals across the State. A total of 3,800 patients has been discharged so far after recovery.

As many as 2.41 lakh people in the State are in home quarantine and 13,976 in institutional quarantine. The State has 1,243 active containment zones and has carried out nearly 2.27 lakh tests.

Key ICMR panel on vaccines dissolved


Key ICMR panel on vaccines dissolved

5 groups set up in National Task Force

10/05/2020, JACOB KOSHY,NEW DELHI

The group was to set up to review evidence and develop concept notes.

The Indian Council for Medical Research (ICMR) has dissolved a key committee, which was part of the National COVID-19 Task Force (NTF) and tasked with developing a research protocol, a team and partners for vaccines and drug development.

The NTF’s key responsibility was to create a “India COVID-19 Clinical Research Collaborative Network”.

The group for ‘Vaccines/Drug Research and Development’ — one among five constituted by ICMR Director-General Balram Bhargava on April 6 — was to identify ‘research priorities, review evidence and develop concept notes’.

However, these objectives were not met, multiple members of the group confirmed to The Hindu. The group met thrice.

One member told The Hindu that the team was probably constituted to help ICMR gain an overview of potential vaccines, existing capabilities in India and research institutions with expertise in specific areas of drug- and vaccine-development.

“I don't think it was a statutory committee. There were experts from different institutions such as DBT (Department of Biotechnology) and CSIR (Council for Scientific and Industrial Research) and we gave our views on the strengths and capabilities that existed,” Srivari Chandrasekhar, Director, CSIR-Indian Institute of Chemical Technology, told The Hindu. “From the discussions, ICMR would have got clarity on where they could best invest their expertise and time. A colleague from ICMR was recording deliberations.”

In the last month, the Department of Science and Technology, the DBT and the CSIR have compiled the existing knowledge base on drugs, diagnostics and potential vaccine development pathways.

According to the ICMR website, members of the group included Gangandeep Kang (Chair), Suman Kanungo (National Institute for Cholera and Enteric Diseases- NICED), Bikash Medhi (Post Graduate Institute for Medical Education and Research), S.S. Das (NICED), Debashish Mitra, (Centre for DNA Fingerprinting and Diagnostics), Sarah Cherian (National Insitute of Virology), Sanjay Mehendale (Hinduja hospital) and Niraj Agrawal (ICMR).

Dr. Mitra told The Hindu that the group was “likely reconstituted” and that he was unaware of further developments. Dr. Kang didn't respond to requests for clarification on whether the terms of reference of the group were achieved. Dr. Bhargava, in response to queries, referred this correspondent to ICMR’s Saturday announcement of the Council partnering with Bharat Biotech International Ltd/ for developing an indigenous potential COVID-19 vaccine.

The other groups constituted as part of the NTF include a clinical research group headed by Dr. Randeep Guleria of AIIMS and on Research on Diagnostics and Biomarkers headed by D.A. Gadkari.

Health Ministry eases discharge guidelines


Health Ministry eases discharge guidelines

Only patients with severe illness to be tested before leaving hospital; negative results not required for mild or moderate cases

10/05/2020, BINDU SHAJAN PERAPPADAN ,NEW DELHI

Final test: Medics checking a COVID-19 patient who has completed the mandatory 14 days of quarantine before his discharge from a hospital in New Delhi on Saturday.PTI

The Union Health Ministry has revised its discharge guidelines for COVID-19 patients, saying only those with severe illness need to test negative (through a swab test) before discharge.

Other categories of patients — very mild, mild, pre-symptomatic and moderate cases — need not be tested before discharge.

The two-page revised guideline replaces the rule that patients could be discharged only after testing negative on the 14th and 21st day after confirmation of the infection.

Three-tier facilities

The guideline states that the revised policy is aligned with the guidelines on the three-tier COVID-19 health facilities and the categorisation of patients based on clinical severity — mild, moderate and severe.

Reacting to the revised guideline, Srinivas Rajkumar, general secretary, All India Institute of Medical Sciences Resident Doctors’ Association, said the decision to send back COVID-19 positive patients without testing was a disaster in the making.

“People sent back untested may spread the virus in the community. What was the government doing for 40 days without arranging enough testing facilities? Is the government ready to sacrifice 2 lakh Indians or more to COVID-19 based on estimates?” he said.

Under the latest guideline, mild, very mild and pre-symptomatic cases admitted to a COVID-19 care facility will undergo regular temperature and pulse monitoring.

“Patient can be discharged after 10 days of symptom onset and if they have no fever for three days. There will be no need for testing prior to discharge,” the revised guideline says.

It adds that at the time of discharge, patients will be advised to follow home isolation for seven more days.

It further clarifies that after discharge from the facility, if patients develop symptoms of fever, cough or breathing difficulty, they must contact a COVID-19 care centre, State helpline or call 1075. Their health will again be followed up through teleconference on Day 14.

Moderate cases will undergo monitoring of body temperature and oxygen saturation.

If fever resolves within three days and a patient maintains saturation above 95% for the next four days (without oxygen support), he or she will be discharged after 10 days of onset of symptoms in case there is no fever without anti-fever drugs, no breathlessness and no need for oxygen.

“There will again be no need for testing prior to discharge, and home isolation for seven days is suggested, with close monitoring of health,” notes the guideline.

Explaining the rationale for discharging mild/moderate cases without testing, a senior ICMR scientist told The Hindu: “Studies outside India have shown that positive test result does not mean the person is still infectious. They may be positive for the virus but can remain non-infectious.”

Spread of infection

He further explained that 10 days after the disease set in, people might not be infectious. But once discharged, they should stay at home for five days. The Ministry’s revision also takes into account the fact that hospitals are reaching their handling capacities.

The U.S. Centers for Disease Control and Prevention too had revised the guidelines on May 6, saying that no negative test for the virus is needed before a hospitalised person can be discharged.

The CDC says decisions about discharge should be based on “clinical status and the ability of the accepting facility to meet their care needs and adhere to recommended infection prevention and control practices”.

(With inputs from

R. Prasad in Chennai)

Shah quashes rumours


Shah quashes rumours, says he is healthy

10/05/2020, SPECIAL CORRESPONDENT,NEW DELHI/AHMEDABAD

Dismissing rumours, Union Home Minister Amit Shah issued a statement on Saturday that he is healthy and not suffering from any ailment. In a signed statement, Mr. Shah said for the past few days rumours have been floating on social media regarding his health and “some people even wished death for me through their tweets”.

“In the past two days, lakhs of people from my party and well-wishers expressed concern about my health ... I would like to clarify today that I am totally healthy and not suffering from any ailment. According to Hindu beliefs, such rumours make a person healthier. So I would like to request everyone to mind their work... ,” he said.

Ahmedabad’s Crime Branch arrested four persons for allegedly spreading misinformation about the health of Mr. Shah by circulating a fake tweet, said Special Commissioner (crime) Ajay Tomar.

ICMR to tie up for Indian Vaccine


ICMR, Bharat Biotech tie up for Indian vaccine

10/05/2020

Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella said in a statement: “We are very proud to participate in this project of national importance with ICMR and NIV. We will do everything to make this program successful in our nation endeavour to combat COVID-19 pandemic.”

Saturday’s announcement is BBIL’s third stated initiative in developing a COVID-19 vaccine. On April 20, the Department of Biotechnology had announced funding support to the company to develop a vaccine candidate utilising the inactivated rabies vector platform. On April 3, the company had said it was working on 'CoroFlu', a one-drop COVID-19 nasal vaccine built on a flu vaccine “backbone” that had proven to be safe in humans. For developing that vaccine, BBIL was part of an international collaboration of virologists at the University of Wisconsin, Madison, and vaccine company FluGen.

Head of Business Development at Bharat Biotech Raches Ella had then said: “Bharat Biotech will manufacture the vaccine, conduct clinical trials and prepare to produce almost 300 million doses of vaccine for global distribution. Under the collaboration agreement, FluGen will transfer its existing manufacturing processes to Bharat Biotech to enable the company to scale up production and produce the vaccine for clinical trials”.

நடுப்பக்கக் கட்டுரைகள் Union Budget: At a Glance The pace of revenue growth has slowed down, according to the Budget Report. Union Budget தி...